Donate For Public and Patients Store Search

S044 - Pearls from the Masters of Dermatological Surgery

Sunday, March 3; 1:00 PM - 4:00 PM

Learning Objectives

Following this course, the attendee should be able to:

  • Demonstrate new concepts in dermatologic oncology and cosmetic dermatology.
  • Determine the subtleties of toxins, fillers and devices.
  • Describe new surgical repairs for dermatologic problems in clinical practice.

Description

This fast-moving session is highly popular with the attendees and the speakers. Each speaker has been selected for their experience and teaching reputation in dermatologic oncology/laser surgery or cosmetic dermatology. Each speaker will present 1-3 pearls in rapid fire fashion. The pearls are all designed to be immediately relevant to clinical practice. Please join us for this highly practical and interactive session.

Disclosures

  • Behshad, Ramona, MD: Castle Biosciences, Inc – A(H); Salveo – A(H);
  • Bertucci, Vince, MD: Allergan, Inc – C(Fees); Allergan, Inc. – A(Fees), I(Fees), SP(H); Croma-Pharma GmbH Austria – A(NC); Galderma Canada, Inc – A(Fees), SP(H); Galderma Laboratories, L.P. – A(Fees); Galderma USA – I(Fees); La Roche-Posay Laboratorie Pharmaceutique – A(Fees), SP(Fees); Merz Aesthetics – A(Fees), C(Fees), I(Fees); Revance Therapeutics, Inc. – C(Fees), I(Fees), SP(Fees); TEOXANE Laboratories – A(OB); Valeant Pharmaceuticals International – C(Fees);
  • Brewer, Jerry D., MD, MS: no financial relationships exist with commercial interests.
  • Dinehart, Scott M., MD: American Board of Dermatology Physician Assistants (ABDPA) – B(NC); Arkansas Dermatology – F(S); Castle Biosciences, Inc – A(H); Genentech, Inc. – A(H), SP(H); Regeneron – A(H), SP(H); Verrica Pharmaceuticals Inc – C(H);
  • Doerfler, Laura B, MD: no financial relationships exist with commercial interests.
  • Glaser, Dee Anna, MD: Allergan, Inc. – I(Grants/Research Funding), O(H); American Society of Dermatologic Surgery – B(NC); Atacama Therapeutics – I(Grants/Research Funding); Brickell Biotech, Inc. – I(Grants/Research Funding); Dermira – A(H), I(Grants/Research Funding), Speaker/Faculty Education(H); Galderma Laboratories, L.P. – A(H); Galderma Research & Development, LLC – I(Grants/Research Funding); Revance Therapeutics, Inc. – I(Grants/Research Funding); Sienna Biopharmaceuticals – I(Grants/Research Funding); Unilever Home & Personal Care USA – A(H);
  • Goldberg, Gerald, MD: Cutera, Inc. – SP(H);
  • Goldman, Glenn D., MD: no financial relationships exist with commercial interests.
  • Hanke, C. William, MD: Athenex – I(Grants/Research Funding); Biofrontera AG – I(Grants/Research Funding); Endo International plc – I(Grants/Research Funding); Genentech, Inc. – A(NC); LEO Pharma, US – A(H), C(H); PellePharm, Inc. – I(Grants/Research Funding); Sun Pharmaceutical Industries Ltd. – C(H);
  • Hruza, George J., MD, MBA: Amgen – SH(NC); Express Scripts (formerly Medco Health Solutions) – SH(NC); Johnson & Johnson Consumer Products Company – SH(NC); MD Complete – SH(NC); Merck & Co., Inc. – SH(NC); Pfizer Inc. – SH(NC); Procter & Gamble Company – SH(NC); Pulse Biosciences – A(NC); Teva – SH(NC); Unilever – SH(NC);
  • Ozog, David M., MD: Biofrontera AG – I(Grants/Research Funding), SH(NC); Galderma USA – I(Grants/Research Funding); miRagen Therapeutics, Inc. – I(Grants/Research Funding);
  • Rullan, Peter P., MD: no financial relationships exist with commercial interests.
  • Sarnoff, Deborah, MD: no financial relationships exist with commercial interests.
  • Tanzi, Elizabeth, MD: Beiersdorf, Inc. – SP(H); Merz Aesthetics – C(OB); Neutrogena Corporation – Independent Contractor(Fees); Sciton Inc. – I(OB); Soliton – A(Fees); Solta Medical – I(OB); Ulthera – SP(H); Zalea, LLC – A(Fees); Zeltiq Aesthetics – A(Fees);
  • Wysong, Ashley, MD, MS: Castle Biosciences – A(NC);
  • Zeitouni, Nathalie C., MD: Biofrontera AG – A(H), I(Grants/Research Funding); Genentech, Inc. – SP(H); MiMedx Group, Inc – C(H); Sanofi/Regeneron – A(H), SP(H); Solgenix, Inc. – I(Grants/Research Funding); Sun Pharmaceutical Industries Ltd. – A(H), I(Grants/Research Funding);
Schedule
Sunday, March 3
1:00 PM
Dr. Hanke / Introduction
1:05 PM
Dr. Behshad / Behshad Pearls
1:15 PM
Dr. Brewer / Brewer Pearls
1:25 PM
Dr. Hruza / Hruza Pearls
1:35 PM
Dr. Wysong / Wysong Pearls
1:45 PM
Dr. Glaser / Glaser Pearls
1:55 PM
Dr. Ozog / Ozog Pearls
2:05 PM
Dr. Goldman / Goldman Pearls
2:15 PM
Dr. Rullan / Rullan Pearls
2:25 PM
Dr. Dinehart / Dinehart Pearls
2:35 PM
Dr. Zeitouni / Zeitouni Pearls
2:45 PM
Dr. Goldberg / Goldberg Pearls
2:55 PM
Dr. Bertucci / Bertucci Pearls
3:05 PM
Dr. Tanzi / Tanzi Pearls
3:15 PM
Dr. Doerfler / Doerfler Pearls
3:25 PM
Dr. Sarnoff / Sarnoff Pearls
3:35 PM
Dr. Hanke / Hanke Pearls
Event Details
  • Date
    Sunday, March 3
  • Time
    1:00 PM - 4:00 PM
  • Location
    Ballroom B
  • CME Credits
    3.00
  • Type
    Restricted
Directors/Co-Directors
  • C. William Hanke, MD, FAAD
Speakers
  • Ashley Wysong, MD, MS, FAAD
  • David M. Ozog, MD, FAAD
  • Deborah Sarnoff, MD, FAAD
  • Dee Anna Glaser, MD, FAAD
  • Elizabeth Tanzi, MD, FAAD
  • George J. Hruza, MD, MBA, FAAD
  • Gerald Goldberg, MD, FAAD - Handout
  • Glenn D. Goldman, MD, FAAD
  • Jerry D. Brewer, MD, MS, FAAD - Handout
  • Laura B Doerfler, MD, FAAD
  • Nathalie C. Zeitouni, MD, FAAD
  • Peter P. Rullan, MD, FAAD - Handout
  • Ramona Behshad, MD, FAAD
  • Scott M. Dinehart, MD, FAAD
  • Vince Bertucci, MD, FAAD